Dr Ajay Sharma to resign as Director - Corporate Affairs of AstraZeneca Pharma India Ruchika Sharma18 Nov 2025 6:18 PM ISTBangalore: AstraZeneca Pharma India has announced the resignation of Dr Ajay Sharma, Director - Corporate Affairs.As per the recent BSE filing,...
PCI Orders States to Update, Verify Pharmacist Database for HPR Integration by November 30 Susmita Roy18 Nov 2025 6:11 PM ISTNew Delhi: In a move to streamline the registration and verification of pharmacists across India, the Pharmacy Council of India (PCI) has directed all...
DoP Invites Applications for Director Post at NIPER Hyderabad with Level-17 Pay Parthika Patel18 Nov 2025 6:01 PM ISTNew Delhi: Through a recent advertisement, the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, has invited applications...
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP Norms Parthika Patel18 Nov 2025 5:54 PM ISTNew Delhi: India's pharmaceutical sector is undergoing one of its most extensive regulatory crackdowns as the apex drug regulator begins nationwide...
Punjab Govt Sets Up Advisory Council, Warns Zero Tolerance on Spurious Drugs Parthika Patel18 Nov 2025 5:46 PM ISTNew Delhi: In a renewed push to tighten drug safety in Punjab, Health and Family Welfare Minister Dr Balbir Singh has called on all pharmaceutical...
Eli Lilly Donanemab secures CDSCO nod for early symptomatic Alzheimer's Disease Ruchika Sharma18 Nov 2025 3:30 PM ISTNew Delhi: Eli Lilly and Company (India) has secured marketing authorization for donanemab (350 mg/20 mL administered every four weeks via intravenous...
Hetero appoints Kshitiz Gadodia to Global Team as President - Finance & Accounts Ruchika Sharma18 Nov 2025 3:19 PM ISTHyderabad: Hetero has appointed Kshitiz Gadodia to its Global Team as President - Finance & Accounts.With over 24 years of experience in finance...
Gilead single tablet regimen of Bictegravir, Lenacapavir for HIV-1 meets primary endpoint in Phase 3 trial Ruchika Sharma18 Nov 2025 12:30 PM ISTFoster City: Gilead Sciences has announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the...
JnJ to acquire Halda Therapeutics for USD 3.05 billion Ruchika Sharma18 Nov 2025 11:15 AM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Halda Therapeutics OpCo, Inc., a...
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof Cream 1% for Adult Psoriasis Susmita Roy17 Nov 2025 7:01 PM ISTNew Delhi: In response to the proposal submitted by Pure and Cure Healthcare, the Subject Expert Committee (SEC) on Dermatology and Allergy,...
Danish Lab Chief Held for Allegedly Supplying Fake Amoxycillin, Cefixime Under SVR Healthcare's Name Parthika Patel17 Nov 2025 6:53 PM ISTAmbala: In a significant enforcement action exposing a dangerous counterfeit drug operation, the Paonta Sahib police have arrested Aniketh Jain, owner...
Himachal Pharma Firm Partner Arrested for Fake Levocetirizine, Pregabalin Production Parthika Patel17 Nov 2025 6:43 PM ISTBaddi: In a major blow to the counterfeit drug network operating in the Baddi industrial zone, the Himachal Pradesh State Drugs Control Administration...
